For example, rimonabant, a CB1R antagonist developed for use as an anti-obesity drug, was withdrawn from the market due to serious adverse effects on mood that resulted in the onset of depression and suicidal ideation (Topol et al. 2010). Here, CNR1 is linked to depressive disorder.